A 12-month, Open Label, Multicenter Pilot Study Evaluating Fingolimod Treatment in terms of Patient Satisfaction in Relapsing Remitting Multiple Sclerosis Patients - FINE Trial

INTRODUCTION: To assess satisfaction and quality of life in patients with relapsing–remitting multiple sclerosis (RRMS) who were receiving fingolimod (0.5 mg/day) for 12 months as a second-line treatment after switching from injectable agents. METHODS: Patients aged 18–65 years with RRMS who fulfill...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Noro Psikiyatr Ars
Autori principali: Demır, Gülşen Akman, Türkoğlu, Recai, Saıp, Sabahattin, Yüceyar, Nur, Efendı, Hüsnü, Turan, Ömer Faruk, Ağan, Kadriye, Terzı, Murat, Boz, Cavit, Tuncer, Aslı, Koçer, Belgin, Kasap, Mithat, Çalişkan, Zeynep
Natura: Artigo
Lingua:Inglês
Pubblicazione: Noro-Psikiyatri Arsivi 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6927087/
https://ncbi.nlm.nih.gov/pubmed/31903032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/npa.2017.20515
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi